- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Algorithmovigilance, lessons from pharmacovigilance ; volume:7 ; number:1 ; day:2 ; month:10 ; year:2024 ; pages:1-6 ; date:12.2024
npj digital medicine ; 7, Heft 1 (2.10.2024), 1-6, 12.2024
- Klassifikation
-
Soziale Probleme, Sozialdienste, Versicherungen
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41746-024-01237-y
- URN
-
urn:nbn:de:101:1-2412192101138.658863887679
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Balendran, Alan
- Benchoufi, Mehdi
- Evgeniou, Theodoros
- Ravaud, Philippe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project
Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
Pharmacovigilance practice among pediatric neurologists from Poland and Germany
Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project
Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
Pharmacovigilance practice among pediatric neurologists from Poland and Germany
Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project
Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
Pharmacovigilance practice among pediatric neurologists from Poland and Germany
Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
Towards robust pharmacovigilance surveillance systems